title: LARC utilization based on type of medical abortion follow-up at an academic center.
abstract: OBJECTIVE
  Compare long-acting contraceptive (LARC) utilization 1 month following a medical abortion among women who chose office or telephone follow-up.
  
  
  METHODS
  We performed a chart review of 79 patients in a new medical abortion service. Women chose a 1-week follow-up in-office or by phone. Contraceptive implants could be placed 1 week and intrauterine contraceptives 4 weeks after mifepristone administration.
  
  
  RESULTS
  LARC methods were desired by 38% and 44% of women, and received by 27% and 29% of women in the office and phone follow-up groups, respectively (p=.8).
  
  
  CONCLUSIONS
  The choice of follow-up in-office or by phone did not change the LARC uptake rate.
  
  
  CONCLUSIONS
  Women should not be discouraged to follow up by phone due to concern for decreased LARC uptake.
authors: Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA.
authors: Kathleen A
authors: KA
authors: Rooney
authors: Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA.
authors: Ashleigh E
authors: AE
authors: Denny
authors: Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA.
authors: Melody Y
authors: MY
authors: Hou
authors: Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA. Electronic address: mitchell.creinin@ucdmc.ucdavis.edu.
authors: Mitchell D
authors: MD
authors: Creinin
mesh_terms: D000328:Adult; D000359:Aftercare; D003267:Contraception / Q000706:statistics & numerical data*; D003271:Contraceptive Agents, Female / Q000008:administration & dosage; D004343:Drug Implants / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage; D009819:Office Visits; D013689:Telephone; D055815:Young Adult
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants; D015735:Mifepristone
keywords: Contraception; Follow-up; Long-acting reversible contraception (LARC); Medical abortion